Hepatitis B virus infection remains one of the leading causes of liver disease, including cirrhosis and hepatocellular carcinoma.

Chronic hepatitis B virus (HBV) infection continues to pose a major global health threat. The virus evades immune responses and antiviral therapies due to the persistence of covalently closed circular ...

A pair of privately-held developers of editing-based therapies have some successes to show for their recent efforts to ...

In contrast, the CRISPR/Cas9 size range is 4000-5000 base pairs ... which is an important marker in patients infected with hepatitis B virus. In particular, HBeAG-negative people who have been ...

Hepatitis B virus (HBV) infection remains an urgent global health concern, affecting hundreds of millions of people and significantly heightening the risk ...

Advances in the gene-editing technology known as CRISPR-Cas9 over the past 15 years have yielded important new insights into ...

Kei Sato was looking for his next big challenge five years ago when it smacked him — and the world — in the face. The ...

A new study has uncovered a molecular mechanism by which rice cells perceive viral infections and initiate antiviral response ...

Researchers at Martin Luther University have developed groundbreaking RNA-based agents that offer high levels of protection ...

The Zika virus builds tiny tunnels, called tunneling nanotubes, to stealthily transport material needed to infect nearby ...